The effects of Intravenous dezocine pretreatment on the incidence and intensity of myoclonus induced by etomidate

Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13004080

Enrollment

Unknown

Registered

2013-11-16

Start date

2013-11-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgical patients

Interventions

dezocine group:dezocine

saline group:0.9% NS

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ASA physical status I or II patients, aged 18-60 years old, undergoing general anesthesia for elective surgical procedures.

Exclusion criteria

Exclusion criteria: Patients with adrenal cortex dysfunction , neuro-logic disease, psychiatric disorders, drug allergy, or who had received sedatives, analgesics, or opioids within the previous 24 h were excluded from the study.

Design outcomes

Primary

Measure	Time frame
mean arterial pressure;heart rate;Pulse Oxygen Saturation;myoclonu;	—

Countries

China

Contacts

Public ContactTieli Dong

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

tlddtl@126.com+86 0371-63620723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026